EUVIMEDEUVIMED entdecken
Crossref

Nanomedicines Promote Cartilage Regeneration in Osteoarthritis by Synergistically Enhancing Chondrogenesis of Mesenchymal Stem Cells and Regulating Inflammatory Environment

Shi-He Cui, Yi Yan, An Lu, Yun Dou, Zhen-Wen Li, Ze-Hang Zhu, Ming-Ze Du, Yue-Feng Zhu, Xin Chen, Xiangyu Wang, Lin-Xia Jiang, Yujie Shi und 4 weitere

ACS Nano · 19.03.2024 · 18 (11) · 8125-8142

DOI: 10.1021/acsnano.3c11848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 07.03.2024. Verfasst von Shi-He Cui und 15 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Phar…. Hauptthemen laut MEDLINE: Osteoarthritis, Cartilage, Articular, Mesenchymal Stem Cells, Synovitis. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Peking University, Ningbo Municipal Bureau of Science and Technology, Beijing Municipal Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a degenerative joint disease characterized by progressive erosion of the articular cartilage and inflammation. Mesenchymal stem cells' (MSCs) transplantation in OA treatment is emerging, but its clinical application is still limited by the low efficiency in oriented differentiation. In our study, to improve the therapeutic efficiencies of MSCs in OA treatment by carbonic anhydrase IX (CA9) siRNA (siCA9)-based inflammation regulation and Kartogenin (KGN)-based chondrogenic differentiation, the combination strategy of MSCs and the nanomedicine codelivering KGN and siCA9 (AHK-CaP/siCA9 NPs) was used. In vitro results demonstrated that these NPs could improve the inflammatory microenvironment through repolarization of M1 macrophages to the M2 phenotype by downregulating the expression levels of CA9 mRNA. Meanwhile, these NPs could also enhance the chondrogenesis of bone marrow-derived mesenchymal stem cells (BMSCs) by upregulating the pro-chondrogenic TGF-β1, ACAN, and Col2α1 mRNA levels. Moreover, in an advanced OA mouse model, compared with BMSCs alone group, the lower synovitis score and OARSI score were found in the group of BMSCs plus AHK-CaP/siCA9 NPs, suggesting that this combination approach could effectively inhibit synovitis and promote cartilage regeneration in OA progression. Therefore, the synchronization of regulating the inflammatory microenvironment through macrophage reprogramming (CA9 gene silencing) and promoting MSCs oriented differentiation through a chondrogenic agent (KGN) may be a potential strategy to maximize the therapeutic efficiency of MSCs for OA treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoarthritisCartilage, ArticularMesenchymal Stem CellsSynovitisMiceAnimalsChondrogenesisNanomedicineCell DifferentiationInflammationRNA, Messenger

Stichwörter der Autor:innen

carbonic anhydrase IXinflammatory microenvironmentkartogeninmesenchymal stem cellsosteoarthritis

Substanzen

RNA, Messenger

Autor:innen und Institutionen

  • Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
  • Department of Sports Medicine, Peking University Third Hospital, Beijing, 100191, China.
  • Laboratory of Innovative Formulations and Pharmaceutical Excipients, Peking University Ningbo Institute of Marine Medicine, Ningbo, 315832, China.

ORCID-Profile: Jian-Cheng Wang

Förderung

  • Peking University
  • Ningbo Municipal Bureau of Science and Technology
  • Beijing Municipal Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Cui, S. H., Yan, Y., Lu, A., Dou, Y., Li, Z. W., Zhu, Z. H., Du, M. Z., Zhu, Y. F., Chen, X., Wang, X., Jiang, L. X., Shi, Y., Liu, X., Zhu, Y. J., Jiang, D., & Wang, J. C. (2024). Nanomedicines Promote Cartilage Regeneration in Osteoarthritis by Synergistically Enhancing Chondrogenesis of Mesenchymal Stem Cells and Regulating Inflammatory Environment. ACS Nano, 18(11), 8125-8142. https://doi.org/10.1021/acsnano.3c11848

Vancouver

Cui SH, Yan Y, Lu A, Dou Y, Li ZW, Zhu ZH, et al. Nanomedicines Promote Cartilage Regeneration in Osteoarthritis by Synergistically Enhancing Chondrogenesis of Mesenchymal Stem Cells and Regulating Inflammatory Environment. ACS Nano. 2024;18(11):8125-8142. doi:10.1021/acsnano.3c11848

BibTeX
@article{Cui2024,
  author = {Cui, Shi-He and Yan, Yi and Lu, An and Dou, Yun and Li, Zhen-Wen and Zhu, Ze-Hang and Du, Ming-Ze and Zhu, Yue-Feng and Chen, Xin and Wang, Xiangyu and Jiang, Lin-Xia and Shi, Yujie and Liu, Xiaoyan and Zhu, Yuan-Jun and Jiang, Dong and Wang, Jian-Cheng},
  title = {Nanomedicines Promote Cartilage Regeneration in Osteoarthritis by Synergistically Enhancing Chondrogenesis of Mesenchymal Stem Cells and Regulating Inflammatory Environment},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {11},
  pages = {8125--8142},
  doi = {10.1021/acsnano.3c11848}
}
Kostenlos starten →